+++ under construction +++
Rupprecht R, Rupprecht C, Di Benedetto B, Rammes G (2022) Neuroinflammation and psychiatric disorders: Relevance of C1q, translocator protein (18 kDa) (TSPO), and neurosteroids. World J Biol Psychiatry 23: 257-263. doi: 10.1080/15622975.2021.1961503.
Rupprecht R, Wetzel CH, Dorostkar M, Herms J, Albert NL, Schwarzbach J, Schumacher M, Neumann ID (2022) Translocator protein (18kDa) TSPO: A new diagnostic or therapeutic target for stress-related disorders? Mol Psychiatry 27: 2918-2926. doi: 10.1038/s41380-022-01561-3.
Rupprecht R, Pradhan A, Kufner M, Brunner LM, Nothdurfter C, Wein S, Schwarzbach J, Rupprecht C, Rammes G (2023) Neurosteroids, translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options. Eur Arch Psychiatry Clinical Neurosci 273: 1477-1487. doi: 10.1007/s00406-022-01532-3.
Riebel M, von Pappenheim B, Kanig C, Nothdurfter C, Wetter TC, Rupprecht R, Schwarzbach J (2023) GABAergic effects of etifoxine and alprazolam assessed by double pulse TMS. Pharmacopsychiatry 56:154-161. doi: 10.1055/a-2078-4823.
Manook A, Baghai TC, Riebel M, Nothdurfter C, Schwarzbach JV, Gessner A, Rupprecht R, Hiergeist A (2023) Short-term effects of etifoxine on human gut microbiome in healthy men. Front Neurosci 17: 118884. doi: 10.3389/fnins.2023.1188847. (open access)
Riebel M, Brunner LM, Nothdurfter C, Wein S, Schwarzbach J, Liere P, Schumacher M, Rupprecht R (2025) Neurosteroids and translocator protein 18 kDa (TSPO) ligands as novel treatment options in depression. Eur Arch Psychiatry Clin Neurosci 275: 1581-1591. doi: 10.1007/s00406-024-01843-7. (open access)
Wein S, Riebel M, Seidel PO, Brunner LM, Wagner V, Nothdurfter C, Rupprecht R, Schwarzbach JV (2024) Local and global effects of sedation in resting-state fMRI: a randomized, placebo-controlled comparison between etifoxine and alprazolam. Neuropsychopharmacology 49: 1738-1748. doi: 10.1038/s41386-024-01884-5. (open access)
Wein S, Riebel M, Brunner LM, Nothdurfter C, Rupprecht R, Schwarzbach J (2025) Data integration with fusion searchlight: classifying brain states from resting-state fMRI. Neuroimage 315: 121263. doi: 10.1016/j.neuroimage.2025.121263 (open access)
Rupprecht R (2025) Neuroactive steroids role in mood disorders and PTSD. Neurosci Biobehav Rev 178:106361. doi:10.1016/j.neubiorev.2025.106361. (open access)
Rupprecht R, Schüle C, Gudermann T (2026) Neuroactive steroids for the treatment of depression and anxiety: gaps and promises. Eur Arch Psychiatry Clin Neurosci 2026 Jan 24. doi: 10.1007/s00406-026-02196-z. Online ahead of print. (open access)
Brunner LM, Riebel M, Wein S, Koller M, Zeman F, Huppertz G, Emmer T, Eberhardt Y, Schwarzbach J, Rupprecht R, Nothdurfter C (2024) The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders- a double-blind, randomized, placebo-controlled proof-of-concept study. Trials 25: 274. doi: 10.1186/s13063-024-08120-x. (open access)